Metaplanet
3350
Nippon Telegraph & Telephone
9432
Mitsubishi Heavy Industries
7011
4
Mitsubishi UFJ Financial Group
8306
5
Remixpoint
3825
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 43
- 00.00%
20min DelayMarket Closed Mar 11 15:30 JST
3.78BMarket Cap-2.36P/E (Static)
44High42Low556.60KVolume43Open43Pre Close23.93MTurnover8952wk High0.67%Turnover Ratio87.95MShares4152wk Low-16.51EPS TTM3.59BFloat Cap2229Historical HighLossP/E (Static)83.40MShs Float41Historical Low-18.21EPS LYR4.65%Amplitude--Dividend TTM3.07P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --